ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 143

$816K Total Retail Price of All Prescriptions

Rank: 9 out of 143

456 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 442 312 1 1
METFORMIN HCL 411 231 2 8
LEVOTHYROXINE SODIUM 403 299 3 3
PRAVASTATIN SODIUM 396 231 4 9
OMEPRAZOLE 317 155 5 5
AMLODIPINE BESYLATE 301 220 6 4
FUROSEMIDE 280 185 7 6
SIMVASTATIN 279 220 8 2
CRESTOR 249 111 9 17
TRAMADOL HCL 202 100 10 16
BYSTOLIC 167 94 11 87
ZOLPIDEM TARTRATE 154 42 12 13
CITALOPRAM HBR 153 116 13 25
METOPROLOL SUCCINATE 149 104 14 14
GLIPIZIDE 145 102 15 55
ATORVASTATIN CALCIUM 140 104 16 7
DONEPEZIL HCL 138 134 17 36
WARFARIN SODIUM 136 120 18 15
GABAPENTIN 135 74 19 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 101 20 21
CARVEDILOL 128 74 21 22
GLIMEPIRIDE 125 105 22 27
FLUTICASONE PROPIONATE 116 73 23 37
NAMENDA 103 103 24 49
TRICOR 102 59 25 71
TAMSULOSIN HCL 98 74 26 28
PROAIR HFA 98 44 26 48
HYDROCHLOROTHIAZIDE 98 77 26 10
ISOSORBIDE MONONITRATE ER 94 54 29 44
METFORMIN HCL ER 93 66 30 63
JANUVIA 93 65 30 54
CELEBREX 89 62 32 70
POTASSIUM CHLORIDE 87 76 33 34
VESICARE 86 69 34 183
PANTOPRAZOLE SODIUM 86 78 34 43
RANITIDINE HCL 80 35 36 41
METOPROLOL TARTRATE 79 68 37 12
NAPROXEN 79 22 37 81
PAROXETINE HCL 77 74 39 79
SERTRALINE HCL 75 73 40 23
SPIRIVA 70 33 41 38
CYMBALTA 69 25 42 47
AZOR 66 49 43 167
ABILIFY 65 19 44 125
DOXAZOSIN MESYLATE 63 34 45 91
NEXIUM 62 0 46 32
ATENOLOL 62 49 46 11
DIOVAN 60 33 48 26
VENTOLIN HFA 60 33 48 110
GLYBURIDE 59 42 R 50 107
TRAZODONE HCL 59 58 50 59
CLOPIDOGREL 56 52 52 33
LEVETIRACETAM 54 0 53 74
ESCITALOPRAM OXALATE 54 29 53 46
PEN NEEDLE 54 15 53 95
TIZANIDINE HCL 53 27 56 141
ALENDRONATE SODIUM 52 33 57 40
ENALAPRIL MALEATE 51 32 58 114
ALLOPURINOL 51 43 58 39
INSULIN SYRINGE 50 20 60 115
VENLAFAXINE HCL ER 50 39 60 118
NASONEX 50 32 60 223
FENOFIBRATE 50 36 60 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.